Skip to main content

Table 4 Univariate analysis for re-stenosis

From: Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement

Variables Hazard ratio (95% CI) P value
Age 1.043 (0.906–1.083) 0.091
Male 1.052 (0.922–1.074) 0.106
Smoking 1.078 (1.003–1.125) 0.015
HTN 1.106 (1.018–1.276) 0.021
DM 1.145 (1.056–1.303) 0.007
Family history 1.008 (0.914–1.022) 0.108
BMI 1.002 (0.967–1.005) 0.455
CHOL 1.089 (0.953–1.117) 0.075
LDL-C 1.227 (1.104–1.420) <0.001
HDL-C 0.895 (0.806–1.007) 0.303
TG 1.007 (0.926–1.011) 0.436
Lp (a) 1.103 (1.048–1.166) 0.014
CREA 1.012 (0.915–1.017) 0.344
BUN 1.005 (0.933–1.009) 0.428
Uric acid 1.017 (0.908–1.032) 0.447
Hs-CRP 1.168 (1.109–1.254) <0.001
Lp-PLA2 1.233 (1.114–1.387) <0.001
LVEF 1.017 (0.908–1.032) 0.160
FS 1.011 (0.933–1.019) 0.174
Anti-platelet 0.826 (0.801–0.944) 0.022
Statins 0.778 (0.723–0.806) <0.001
Medications for HTN 0.909 (0.886–1.005) 0.096
Medications for DM 0.845 (0.817–0.896) 0.018
  1. Denote: CI = confidence interval.